Xeris Biopharma Holdings Inc (XERS)
3.05
-0.10
(-3.17%)
USD |
NASDAQ |
Nov 14, 16:00
3.14
+0.09
(+2.95%)
After-Hours: 06:51
Xeris Biopharma Holdings Gross Profit (Annual): 135.27M for Dec. 31, 2023
Gross Profit (Annual) Chart
Historical Gross Profit (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 135.27M |
| December 31, 2022 | 87.61M |
| December 31, 2021 | 36.27M |
| December 31, 2020 | 11.11M |
| Date | Value |
|---|---|
| December 31, 2019 | 1.119M |
| December 31, 2018 | 2.423M |
| December 31, 2017 | 1.552M |
| December 31, 2016 | 1.067M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Annual) Range, Past 5 Years
1.119M
Minimum
2019
135.27M
Maximum
2023
54.28M
Average
36.27M
Median
2021
Gross Profit (Annual) Benchmarks
| Zevra Therapeutics Inc | 24.52M |
| NovaBay Pharmaceuticals Inc | 7.895M |
| Palatin Technologies Inc | 4.392M |
| iBio Inc | -- |
| Theriva Biologics Inc | -- |